Company

XtalPi Partners with Pierre Fabre Laboratories – AI‑Powered Drug Discovery Alliance Targeting Novel Oncology Therapies
AIHKG: 2228

XtalPi Partners with Pierre Fabre Laboratories – AI‑Powered Drug Discovery Alliance Targeting Novel Oncology Therapies

XtalPi Inc. (HKG: 2228) and Pierre Fabre Laboratories announced a strategic partnership agreement to jointly launch multiple R&D projects in oncology aimed at discovering novel clinical drug candidates, with the…

Genoria and iCamuno Biotherapeutics Establish Joint Venture in Shanghai Free Trade Zone – Pioneering AI‑Driven Autologous Cell Therapy

Genoria and iCamuno Biotherapeutics Establish Joint Venture in Shanghai Free Trade Zone – Pioneering AI‑Driven Autologous Cell Therapy

Bayer Signs Strategic Agreements with ACITS and GHIC at CIIE – Building an Open Innovation Ecosystem in Urological Oncology

Bayer Signs Strategic Agreements with ACITS and GHIC at CIIE – Building an Open Innovation Ecosystem in Urological Oncology

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Cell Store and Cygenta Forge Strategic Alliance in Cell and Gene Therapy Field
Cell StoreCell-therapy

Cell Store and Cygenta Forge Strategic Alliance in Cell and Gene Therapy Field

InnoCare Pharma's Orelabrutinib Shows Efficacy in RRMS at ACTRIMS Forum
Clinical trial resultsHKG: 9969

InnoCare Pharma’s Orelabrutinib Shows Efficacy in RRMS at ACTRIMS Forum

Jiangsu Hengrui's HRS-1301 Receives NMPA Approval for Hyperlipidemia
Clinical trial approval / initiationCVD

Jiangsu Hengrui’s HRS-1301 Receives NMPA Approval for Hyperlipidemia

Hepalink Pharmaceutical's Enoparin Receives Argentina Approval for Thromboembolic Diseases
CVDHepalink Pharmaceutical

Hepalink Pharmaceutical’s Enoparin Receives Argentina Approval for Thromboembolic Diseases

Show More